Veterinary Medicines

Porcilis Glässer Vet Suspension for injection for pigs

Authorised
  • Haemophilus parasuis, serotype 5, strain 4800, Inactivated
  • Haemophilus parasuis, serotype 5, strain 4800, Inactivated
  • Haemophilus parasuis, serotype 5, strain 4800, Inactivated
Download as PDF

Product identification

Medicine name:
Porcilis Glässer Vet Suspension for injection for pigs
Porcilis Glässer suspensie voor injectie voor varkens
Active substance:
  • Haemophilus parasuis, serotype 5, strain 4800, Inactivated
  • Haemophilus parasuis, serotype 5, strain 4800, Inactivated
  • Haemophilus parasuis, serotype 5, strain 4800, Inactivated
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Haemophilus parasuis, serotype 5, strain 4800, Inactivated
    9.10
    enzyme-linked immunosorbent assay unit
    /
    2.00
    millilitre(s)
  • Haemophilus parasuis, serotype 5, strain 4800, Inactivated
    9.10
    enzyme-linked immunosorbent assay unit
    /
    2.00
    millilitre(s)
  • Haemophilus parasuis, serotype 5, strain 4800, Inactivated
    9.10
    enzyme-linked immunosorbent assay unit
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        0
        day
      • Meat and offal
        0
        day
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB07
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Available in:
  • Netherlands
Package description:
  • 6 x 20 ml (10 doses) in glass type I vials in carton (60 doses)
  • 100 ml (50 doses) in PET vials in carton
  • 6 x 50 ml (25 doses) in glass type I vials in carton (150 doses)
  • 12 x 20 ml (10 doses) in PET vials in carton (120 doses)
  • 20 ml (10 doses) in PET vials in carton
  • 50 ml (25 doses) in glass type I vials in carton
  • 100 ml (50 doses) in glass type I vials in carton
  • 20 ml (10 doses) in glass type I vials in carton
  • 6 x 20 ml (10 doses) in PET vials in carton (60 doses)
  • 6 x 50 ml (25 doses) in PET vials in carton (150 doses)
  • 12 x 100 ml (50 doses) in glass type I vials in carton (600 doses)
  • 12 x 50 ml (25 doses) in PET vials in carton (300 doses)
  • 12 x 50 ml (25 doses) in glass type I vials in cardboard box (300 doses)
  • 6 x 100 ml (50 doses) in glass type I vials in carton (300 doses)
  • 12 x 100 ml (50 doses) in PET vials in carton (600 doses)
  • 12 x 20 ml (10 doses) in glass type I vials in carton (120 doses)
  • 6 x 100 ml (50 doses) in PET vials in cardboard box (300 doses)
  • 50 ml (25 doses) in PET vials in cardboard box

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Intervet Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 10172
Date of authorisation status change:
Reference member state:
  • Denmark
Procedure number:
  • DK/V/0107/001
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • Czechia
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 6/11/2024
Download

PI.pdf

English (PDF)
Published on: 27/01/2022
Download